Evidence map›Paper›PMID 39012593›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2024

Neuroepigenetic Editing.

Peter J Hamilton, Carissa J Lim, Eric J Nestler, Elizabeth A Heller

Abstract readReview
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Sex-specific role of the 5-HTNature communications · 2025
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter J HamiltonDepartment of Anatomy & Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Carissa J LimDepartment of Systems Pharmacology and Translational Therapeutics, The University of Pennsylvania, Philadelphia, PA, USA.
Eric J NestlerThe Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Elizabeth A HellerDepartment of Systems Pharmacology and Translational Therapeutics, The University of Pennsylvania, Philadelphia, PA, USA. eheller@pennmedicine.upenn.edu.

Funding

Transcription Factors in Stimulant and Opioid ActionP01DA047233 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YASMIN L. HURD · 2019 to 2026
$16.5M
Small molecule modulators of ΔFosB FunctionR01DA040621 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI NESTLER, ERIC J., ROBISON, ALFRED J · 2016 to 2025
$7.1M
Molecular Studies of Cocaine Action in BrainR01DA007359 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1991 to 2025
$5.6M
Cell type transcriptional mechanisms of polysubstance choiceR01DA058958 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Matthew L Banks, Peter James Hamilton · 2023 to 2026
$1.8M
Reprogramming KZFP function to understand drug-specific transcription and behaviorR01DA058089 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Peter James Hamilton · 2024 to 2026
$1.5M
Pharmacology of Stimulant ChoiceR01DA055825 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Matthew L Banks, Jose Miguel Eltit · 2023 to 2026
$1.4M
Using CRISPR tools to uncover the role of CREB-gene regulation in drug abuseR00DA045795 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAMILTON, PETER JAMES · 2020 to 2022
$739k
Neurocognitive, genetic and socioenvironmental influences on a developmental precursors to addiction: A cross-species studyR34DA061267 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BANKS, MATTHEW L, BOUNTRESS, KAITLIN ELIZABETH · 2024 to 2025
$689k
NIDA NIH HHS P01 DA047233NIDA NIH HHS R00 DA045795NIDA NIH HHS R01 DA007359NIDA NIH HHS R01 DA040621NIDA NIH HHS R01 DA055825NIDA NIH HHS R01 DA058089NIDA NIH HHS R01 DA058958NIDA NIH HHS R34 DA061267
6 · The paper itself

Abstract

Epigenetic regulation is intrinsic to basic neurobiological function as well as neurological disease. Regulation of chromatin-modifying enzymes in the brain is critical during both development and adulthood and in response to external stimuli. Biochemical studies are complemented by numerous next-generation sequencing (NGS) studies that quantify global changes in gene expression, chromatin accessibility, histone and DNA modifications in neurons and glial cells. Neuroepigenetic editing tools are essential to distinguish between the mere presence and functional relevance of histone and DNA modifications to gene transcription in the brain and animal behavior. This review discusses current advances in neuroepigenetic editing, highlighting methodological considerations pertinent to neuroscience, such as delivery methods and the spatiotemporal specificity of editing and it demonstrates the enormous potential of epigenetic editing for basic neurobiological research and therapeutic application.

Indexed as

Epigenesis, GeneticGene EditingAnimalsBrainChromatinCRISPR-Cas SystemsHigh-Throughput Nucleotide SequencingHistonesHumansNeuronsChromatinHistoneschromatinEpigenetic editingneurosciencepsychiatric disease

Identifiers

PMID39012593
PMCPMC11520296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.